Industry Research Reports
Home > Reports > Chemical & Material > Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 76 Pages
Report ld: 4161160
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Astragaloside IV Market Size(US$)
CAGR 2025-2031
3.3%
Market Size,2031
USD 95.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 78.5 million
Market Forecast in 2031(Value)
US$ 95.3 million
CAGR
3.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Astragaloside IV market size was US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Astragaloside IV extract from astragalus Root.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
The global Astragaloside IV market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Astragaloside IV market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
By Company
- NandR Bio Industries
- Zenergy Korea Corporation
- Bio-norm
- Wuhan Vanz Pharm
- Shaanxi Pioneer Biotech
- Xi'an Lyphar Biotech
- Xian Pincredit Bio-Tech
- Shaanxi Fuheng (FH) Biotechnology
- Nanjing NutriHerb BioTech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 0.1
- 0.98
- Others
Segment by Application
- Food Industry
- Pharmaceuticals Industry
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Astragaloside IV in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Astragaloside IV manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Astragaloside IV revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Astragaloside IV Product Scope
1.2 Astragaloside IV by Type
1.2.1 Global Astragaloside IV Sales by Type (2020 & 2024 & 2031)
1.2.2 0.1
1.2.3 0.98
1.2.4 Others
1.3 Astragaloside IV by Application
1.3.1 Global Astragaloside IV Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Food Industry
1.3.3 Pharmaceuticals Industry
1.3.4 Others
1.4 Global Astragaloside IV Market Estimates and Forecasts (2020-2031)
1.4.1 Global Astragaloside IV Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Astragaloside IV Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Astragaloside IV Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Astragaloside IV Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Astragaloside IV Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Astragaloside IV Sales Market Share by Region (2020-2025)
2.2.2 Global Astragaloside IV Revenue Market Share by Region (2020-2025)
2.3 Global Astragaloside IV Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Astragaloside IV Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Astragaloside IV Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Astragaloside IV Market Size and Prospective (2020-2031)
2.4.2 Europe Astragaloside IV Market Size and Prospective (2020-2031)
2.4.3 China Astragaloside IV Market Size and Prospective (2020-2031)
2.4.4 Japan Astragaloside IV Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Astragaloside IV Historic Market Review by Type (2020-2025)
3.1.1 Global Astragaloside IV Sales by Type (2020-2025)
3.1.2 Global Astragaloside IV Revenue by Type (2020-2025)
3.1.3 Global Astragaloside IV Price by Type (2020-2025)
3.2 Global Astragaloside IV Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Astragaloside IV Sales Forecast by Type (2026-2031)
3.2.2 Global Astragaloside IV Revenue Forecast by Type (2026-2031)
3.2.3 Global Astragaloside IV Price Forecast by Type (2026-2031)
3.3 Different Types Astragaloside IV Representative Players
4 Global Market Size by Application
4.1 Global Astragaloside IV Historic Market Review by Application (2020-2025)
4.1.1 Global Astragaloside IV Sales by Application (2020-2025)
4.1.2 Global Astragaloside IV Revenue by Application (2020-2025)
4.1.3 Global Astragaloside IV Price by Application (2020-2025)
4.2 Global Astragaloside IV Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Astragaloside IV Sales Forecast by Application (2026-2031)
4.2.2 Global Astragaloside IV Revenue Forecast by Application (2026-2031)
4.2.3 Global Astragaloside IV Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Astragaloside IV Application
5 Competition Landscape by Players
5.1 Global Astragaloside IV Sales by Players (2020-2025)
5.2 Global Top Astragaloside IV Players by Revenue (2020-2025)
5.3 Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Astragaloside IV as of 2024)
5.4 Global Astragaloside IV Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Astragaloside IV, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Astragaloside IV, Product Type & Application
5.7 Global Key Manufacturers of Astragaloside IV, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Astragaloside IV Sales by Company
6.1.1.1 North America Astragaloside IV Sales by Company (2020-2025)
6.1.1.2 North America Astragaloside IV Revenue by Company (2020-2025)
6.1.2 North America Astragaloside IV Sales Breakdown by Type (2020-2025)
6.1.3 North America Astragaloside IV Sales Breakdown by Application (2020-2025)
6.1.4 North America Astragaloside IV Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Astragaloside IV Sales by Company
6.2.1.1 Europe Astragaloside IV Sales by Company (2020-2025)
6.2.1.2 Europe Astragaloside IV Revenue by Company (2020-2025)
6.2.2 Europe Astragaloside IV Sales Breakdown by Type (2020-2025)
6.2.3 Europe Astragaloside IV Sales Breakdown by Application (2020-2025)
6.2.4 Europe Astragaloside IV Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Astragaloside IV Sales by Company
6.3.1.1 China Astragaloside IV Sales by Company (2020-2025)
6.3.1.2 China Astragaloside IV Revenue by Company (2020-2025)
6.3.2 China Astragaloside IV Sales Breakdown by Type (2020-2025)
6.3.3 China Astragaloside IV Sales Breakdown by Application (2020-2025)
6.3.4 China Astragaloside IV Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Astragaloside IV Sales by Company
6.4.1.1 Japan Astragaloside IV Sales by Company (2020-2025)
6.4.1.2 Japan Astragaloside IV Revenue by Company (2020-2025)
6.4.2 Japan Astragaloside IV Sales Breakdown by Type (2020-2025)
6.4.3 Japan Astragaloside IV Sales Breakdown by Application (2020-2025)
6.4.4 Japan Astragaloside IV Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 NandR Bio Industries
7.1.1 NandR Bio Industries Company Information
7.1.2 NandR Bio Industries Business Overview
7.1.3 NandR Bio Industries Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.1.4 NandR Bio Industries Astragaloside IV Products Offered
7.1.5 NandR Bio Industries Recent Development
7.2 Zenergy Korea Corporation
7.2.1 Zenergy Korea Corporation Company Information
7.2.2 Zenergy Korea Corporation Business Overview
7.2.3 Zenergy Korea Corporation Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Zenergy Korea Corporation Astragaloside IV Products Offered
7.2.5 Zenergy Korea Corporation Recent Development
7.3 Bio-norm
7.3.1 Bio-norm Company Information
7.3.2 Bio-norm Business Overview
7.3.3 Bio-norm Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bio-norm Astragaloside IV Products Offered
7.3.5 Bio-norm Recent Development
7.4 Wuhan Vanz Pharm
7.4.1 Wuhan Vanz Pharm Company Information
7.4.2 Wuhan Vanz Pharm Business Overview
7.4.3 Wuhan Vanz Pharm Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Wuhan Vanz Pharm Astragaloside IV Products Offered
7.4.5 Wuhan Vanz Pharm Recent Development
7.5 Shaanxi Pioneer Biotech
7.5.1 Shaanxi Pioneer Biotech Company Information
7.5.2 Shaanxi Pioneer Biotech Business Overview
7.5.3 Shaanxi Pioneer Biotech Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Shaanxi Pioneer Biotech Astragaloside IV Products Offered
7.5.5 Shaanxi Pioneer Biotech Recent Development
7.6 Xi'an Lyphar Biotech
7.6.1 Xi'an Lyphar Biotech Company Information
7.6.2 Xi'an Lyphar Biotech Business Overview
7.6.3 Xi'an Lyphar Biotech Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Xi'an Lyphar Biotech Astragaloside IV Products Offered
7.6.5 Xi'an Lyphar Biotech Recent Development
7.7 Xian Pincredit Bio-Tech
7.7.1 Xian Pincredit Bio-Tech Company Information
7.7.2 Xian Pincredit Bio-Tech Business Overview
7.7.3 Xian Pincredit Bio-Tech Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Xian Pincredit Bio-Tech Astragaloside IV Products Offered
7.7.5 Xian Pincredit Bio-Tech Recent Development
7.8 Shaanxi Fuheng (FH) Biotechnology
7.8.1 Shaanxi Fuheng (FH) Biotechnology Company Information
7.8.2 Shaanxi Fuheng (FH) Biotechnology Business Overview
7.8.3 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Products Offered
7.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Development
7.9 Nanjing NutriHerb BioTech
7.9.1 Nanjing NutriHerb BioTech Company Information
7.9.2 Nanjing NutriHerb BioTech Business Overview
7.9.3 Nanjing NutriHerb BioTech Astragaloside IV Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Nanjing NutriHerb BioTech Astragaloside IV Products Offered
7.9.5 Nanjing NutriHerb BioTech Recent Development
8 Astragaloside IV Manufacturing Cost Analysis
8.1 Astragaloside IV Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Astragaloside IV
8.4 Astragaloside IV Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Astragaloside IV Distributors List
9.3 Astragaloside IV Customers
10 Astragaloside IV Market Dynamics
10.1 Astragaloside IV Industry Trends
10.2 Astragaloside IV Market Drivers
10.3 Astragaloside IV Market Challenges
10.4 Astragaloside IV Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Astragaloside IV Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Astragaloside IV Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Astragaloside IV Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Astragaloside IV Sales (MT) by Region (2020-2025)
Table 5. Global Astragaloside IV Sales Market Share by Region (2020-2025)
Table 6. Global Astragaloside IV Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Astragaloside IV Revenue Share by Region (2020-2025)
Table 8. Global Astragaloside IV Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Astragaloside IV Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Astragaloside IV Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Astragaloside IV Revenue Share Forecast by Region (2026-2031)
Table 12. Global Astragaloside IV Sales by Type (MT) & (2020-2025)
Table 13. Global Astragaloside IV Sales Share by Type (2020-2025)
Table 14. Global Astragaloside IV Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Astragaloside IV Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Astragaloside IV Sales by Type (MT) & (2026-2031)
Table 17. Global Astragaloside IV Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Astragaloside IV Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Astragaloside IV Sales by Application (MT) & (2020-2025)
Table 21. Global Astragaloside IV Sales Share by Application (2020-2025)
Table 22. Global Astragaloside IV Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Astragaloside IV Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Astragaloside IV Sales by Application (MT) & (2026-2031)
Table 25. Global Astragaloside IV Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Astragaloside IV Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Astragaloside IV Application
Table 28. Global Astragaloside IV Sales by Company (MT) & (2020-2025)
Table 29. Global Astragaloside IV Sales Share by Company (2020-2025)
Table 30. Global Astragaloside IV Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Astragaloside IV Revenue Share by Company (2020-2025)
Table 32. Global Astragaloside IV by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Astragaloside IV as of 2024)
Table 33. Global Market Astragaloside IV Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Astragaloside IV, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Astragaloside IV, Product Type & Application
Table 36. Global Key Manufacturers of Astragaloside IV, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Astragaloside IV Sales by Company (2020-2025) & (MT)
Table 39. North America Astragaloside IV Sales Market Share by Company (2020-2025)
Table 40. North America Astragaloside IV Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Astragaloside IV Revenue Market Share by Company (2020-2025)
Table 42. North America Astragaloside IV Sales by Type (2020-2025) & (MT)
Table 43. North America Astragaloside IV Sales Market Share by Type (2020-2025)
Table 44. North America Astragaloside IV Sales by Application (2020-2025) & (MT)
Table 45. North America Astragaloside IV Sales Market Share by Application (2020-2025)
Table 46. Europe Astragaloside IV Sales by Company (2020-2025) & (MT)
Table 47. Europe Astragaloside IV Sales Market Share by Company (2020-2025)
Table 48. Europe Astragaloside IV Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Astragaloside IV Revenue Market Share by Company (2020-2025)
Table 50. Europe Astragaloside IV Sales by Type (2020-2025) & (MT)
Table 51. Europe Astragaloside IV Sales Market Share by Type (2020-2025)
Table 52. Europe Astragaloside IV Sales by Application (2020-2025) & (MT)
Table 53. Europe Astragaloside IV Sales Market Share by Application (2020-2025)
Table 54. China Astragaloside IV Sales by Company (2020-2025) & (MT)
Table 55. China Astragaloside IV Sales Market Share by Company (2020-2025)
Table 56. China Astragaloside IV Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Astragaloside IV Revenue Market Share by Company (2020-2025)
Table 58. China Astragaloside IV Sales by Type (2020-2025) & (MT)
Table 59. China Astragaloside IV Sales Market Share by Type (2020-2025)
Table 60. China Astragaloside IV Sales by Application (2020-2025) & (MT)
Table 61. China Astragaloside IV Sales Market Share by Application (2020-2025)
Table 62. Japan Astragaloside IV Sales by Company (2020-2025) & (MT)
Table 63. Japan Astragaloside IV Sales Market Share by Company (2020-2025)
Table 64. Japan Astragaloside IV Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Astragaloside IV Revenue Market Share by Company (2020-2025)
Table 66. Japan Astragaloside IV Sales by Type (2020-2025) & (MT)
Table 67. Japan Astragaloside IV Sales Market Share by Type (2020-2025)
Table 68. Japan Astragaloside IV Sales by Application (2020-2025) & (MT)
Table 69. Japan Astragaloside IV Sales Market Share by Application (2020-2025)
Table 70. NandR Bio Industries Company Information
Table 71. NandR Bio Industries Description and Business Overview
Table 72. NandR Bio Industries Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. NandR Bio Industries Astragaloside IV Product
Table 74. NandR Bio Industries Recent Development
Table 75. Zenergy Korea Corporation Company Information
Table 76. Zenergy Korea Corporation Description and Business Overview
Table 77. Zenergy Korea Corporation Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Zenergy Korea Corporation Astragaloside IV Product
Table 79. Zenergy Korea Corporation Recent Development
Table 80. Bio-norm Company Information
Table 81. Bio-norm Description and Business Overview
Table 82. Bio-norm Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Bio-norm Astragaloside IV Product
Table 84. Bio-norm Recent Development
Table 85. Wuhan Vanz Pharm Company Information
Table 86. Wuhan Vanz Pharm Description and Business Overview
Table 87. Wuhan Vanz Pharm Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Wuhan Vanz Pharm Astragaloside IV Product
Table 89. Wuhan Vanz Pharm Recent Development
Table 90. Shaanxi Pioneer Biotech Company Information
Table 91. Shaanxi Pioneer Biotech Description and Business Overview
Table 92. Shaanxi Pioneer Biotech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Shaanxi Pioneer Biotech Astragaloside IV Product
Table 94. Shaanxi Pioneer Biotech Recent Development
Table 95. Xi'an Lyphar Biotech Company Information
Table 96. Xi'an Lyphar Biotech Description and Business Overview
Table 97. Xi'an Lyphar Biotech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Xi'an Lyphar Biotech Astragaloside IV Product
Table 99. Xi'an Lyphar Biotech Recent Development
Table 100. Xian Pincredit Bio-Tech Company Information
Table 101. Xian Pincredit Bio-Tech Description and Business Overview
Table 102. Xian Pincredit Bio-Tech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Xian Pincredit Bio-Tech Astragaloside IV Product
Table 104. Xian Pincredit Bio-Tech Recent Development
Table 105. Shaanxi Fuheng (FH) Biotechnology Company Information
Table 106. Shaanxi Fuheng (FH) Biotechnology Description and Business Overview
Table 107. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product
Table 109. Shaanxi Fuheng (FH) Biotechnology Recent Development
Table 110. Nanjing NutriHerb BioTech Company Information
Table 111. Nanjing NutriHerb BioTech Description and Business Overview
Table 112. Nanjing NutriHerb BioTech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Nanjing NutriHerb BioTech Astragaloside IV Product
Table 114. Nanjing NutriHerb BioTech Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Astragaloside IV Distributors List
Table 118. Astragaloside IV Customers List
Table 119. Astragaloside IV Market Trends
Table 120. Astragaloside IV Market Drivers
Table 121. Astragaloside IV Market Challenges
Table 122. Astragaloside IV Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Astragaloside IV Product Picture
Figure 2. Global Astragaloside IV Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Astragaloside IV Sales Market Share by Type in 2024 & 2031
Figure 4. 0.1 Product Picture
Figure 5. 0.98 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Astragaloside IV Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Astragaloside IV Sales Market Share by Application in 2024 & 2031
Figure 9. Food Industry Examples
Figure 10. Pharmaceuticals Industry Examples
Figure 11. Others Examples
Figure 12. Global Astragaloside IV Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Astragaloside IV Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Astragaloside IV Sales (MT) Growth Rate (2020-2031)
Figure 15. Global Astragaloside IV Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 16. Astragaloside IV Report Years Considered
Figure 17. Global Market Astragaloside IV Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Astragaloside IV Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Astragaloside IV Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Astragaloside IV Sales (MT) Growth Rate (2020-2031)
Figure 21. Europe Astragaloside IV Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Astragaloside IV Sales (MT) Growth Rate (2020-2031)
Figure 23. China Astragaloside IV Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Astragaloside IV Sales (MT) Growth Rate (2020-2031)
Figure 25. Japan Astragaloside IV Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Astragaloside IV Sales (MT) Growth Rate (2020-2031)
Figure 27. Global Astragaloside IV Revenue Share by Type (2020-2025)
Figure 28. Global Astragaloside IV Sales Share by Type (2026-2031)
Figure 29. Global Astragaloside IV Revenue Share by Type (2026-2031)
Figure 30. Global Astragaloside IV Revenue Share by Application (2020-2025)
Figure 31. Global Astragaloside IV Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Astragaloside IV Sales Share by Application (2026-2031)
Figure 33. Global Astragaloside IV Revenue Share by Application (2026-2031)
Figure 34. Global Astragaloside IV Sales Share by Company (2024)
Figure 35. Global Astragaloside IV Revenue Share by Company (2024)
Figure 36. Global 5 Largest Astragaloside IV Players Market Share by Revenue in Astragaloside IV: 2020 & 2024
Figure 37. Astragaloside IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Astragaloside IV
Figure 39. Manufacturing Process Analysis of Astragaloside IV
Figure 40. Astragaloside IV Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Astragaloside IV market?
The top companies in the global Astragaloside IV market are NandR Bio Industries、Zenergy Korea Corporation、Bio-norm.
What is the annual compound growth rate of the global Astragaloside IV market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Astragaloside IV in 2025?
What was the global market size of Astragaloside IV in 2031?
Related Reports
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astragaloside IV was estimated to be worth US$ 78.46 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 127
USD 3950.00
(Single User License)
Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 128
USD 2900.00
(Single User License)
Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 131
USD 4900.00
(Single User License)
Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-02-21
Pages: 89
USD 2900.00
(Single User License)
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 94
USD 3950.00
(Single User License)
Global Astragaloside IV Market Insights, Forecast to 2030
Astragaloside IV extract from astragalus Root.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published Date: 2024-01-10
Pages: 88
USD 2900.00
(Single User License)
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astragaloside IV was estimated to be worth US$ 78.46 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-07-09
Pages: 127
USD 3950.00 (Single User License)Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-04-25
Pages: 128
USD 2900.00 (Single User License)Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 131
USD 4900.00 (Single User License)Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-02-21
Pages: 89
USD 2900.00 (Single User License)Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 94
USD 3950.00 (Single User License)Global Astragaloside IV Market Insights, Forecast to 2030
Astragaloside IV extract from astragalus Root.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published: 2024-01-10
Pages: 88
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now